ASCENTAGE PHARMA GROUP INTERNATIONAL
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
AAPG | US
Overview
Corporate Details
- ISIN(s):
- US04390B1052
- LEI:
- Country:
- United States of America
- Address:
- 68 XINQING ROAD, 0 SUZHOU , JIANGSU
- Website:
- https://www.ascentage.cn/
- Sector:
- Manufacturing
Description
Ascentage Pharma Group International is a global, clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for cancers, chronic hepatitis B, and age-related diseases. The company aims to address unmet medical needs by creating first-in-class and best-in-class small-molecule drugs. Its core scientific expertise is in structure-based drug design and targeting key proteins that regulate apoptosis (programmed cell death). The company's pipeline features multiple drug candidates being evaluated in numerous clinical studies globally. Key assets include olverembatinib, a third-generation BCR-ABL inhibitor; lisaftoclax (APG-2575), a selective Bcl-2 inhibitor; and pelcitoclax (APG-1252), a dual Bcl-2/Bcl-xL inhibitor. These candidates have received multiple Fast Track, Orphan Drug, and Rare Pediatric Disease designations from global regulatory authorities.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all ASCENTAGE PHARMA GROUP INTERNATIONAL filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ASCENTAGE PHARMA GROUP INTERNATIONAL
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ASCENTAGE PHARMA GROUP INTERNATIONAL via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
